Prenetics global ltd PRE.US Value Analysis

US StockHealth Care
(No presentation for PRE)

PRE Value Score

3

24

15

Limited Growth
  • AI analysis rates PRE  with a lower value score of 2.
  • It is mainly due to  unstable operating cash flow, along with potential value may be lower.
  • Over the past 3 months, PRE has maintained a consecutive value rating of 2.0, slightly higher than the rating of 0.5 over the past 3 years. However, growth opportunities for enterprise value remain relatively low.
  • Compared to all stocks in the Health Care sector, PRE has a medium value rating.

PRE Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2024/12/16 (Weekly Update)

PRE Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

PRE Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
-0.94
-
30.6%
10.5M
-
-12.5%
-137.2%
2024Q2
-0.88
-
2.3%
7.78M
-
1%
-180.5%
2024Q1
-0.15
-
-83.9%
5.94M
-
-22.8%
-133.6%
2022Q3
0.9
-
900%
17.7M
-
-73.4%
-18.7%

Update to 2025/5/9 (Quarterly Update)

PRE Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

PRE Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry
Exit

The Backtest Result of PRE from 2021/07 till Now

-
Cumulative Return
-
Annual Return
-
Volatility
-
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from July, 2021 to May, 2025. (Total Trades: 0)

PRESectorUS Overall Market
Wining Rate-44%54%
Avg Return-63.5%72.8%
Avg Profit-198.7%166%
Avg Loss--44.7%-34.6%
Avg Risk-Reward Ratio-444.3%479.7%

Update to 2025/5/9 (Daily Update)

Top 10 High Relevance to PRE Value Score